Clinical Trial Update: AM-101 in the Treatment of Post-Acute Tinnitus 1 [Phase 3]

View source ↗

Summary

Auris Medical reports the completion of a Phase 3 trial evaluating AM-101 for post-acute tinnitus, with results posted on 2018-03-09.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinnitus

Drugs mentioned

• AM 101

Snippet

Sponsor: Auris Medical, Inc. | Conditions: Tinnitus | Phase 3 | Status: COMPLETED | Results posted: 2018-03-09